Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home

ExpertiseUpdated on 26 April 2026

Services

Sanjee Tawde

VP - Business Development & Sales at Partex.AI

Frankfurt, Germany

About

Partex.AI is the world's largest AI-powered therapeutic asset accelerator, using Big Data, Generative AI, and proprietary models to optimize drug discovery and development from lab to patient.

Therapeutics

Focuses on identifying and de-risking late-stage preclinical/early clinical assets (especially oncology), incubating promising drugs in SPVs, and optimizing development paths with wet-lab validated AI predictions.

Exchange

Enables pharma/biotech partnerships for in/out-licensing deprioritized assets, using AI for evaluation, repositioning, and value-based deals across the pipeline.

Labs

Partex.AI Labs (Amgen spin-off in Regensburg) offers CRO services: custom assay development, cell line engineering, high-throughput screening (HTS with >150k library), bioactivity assessments, quantitative biology, and ADMETron™ for predictive ADMET/Tox from SMILES—delivering >300M data points and 95% success across targets like GPCRs and enzymes.

Data

Leverages Real-World Data (RWD) partnerships for equitable, patient-owned insights, enhancing clinical trials, treatment optimization, and decision-making via a centralized data lake.

Field

  • Biotech, Pharma and Cosmetics
  • Healthcare

Similar opportunities